Epirubicin Hydrochloride
Who holds supplier records for Epirubicin Hydrochloride? 9 organisations hold a current record for Epirubicin Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 8 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (2), Japan (1), Switzerland (1), Italy (1) and 3 other countries (3); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Epirubicin Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/epirubicin-hydrochloride
Reading the evidence
- 9 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 6 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (9)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Epirubicin Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Shandong New Time Pharmaceutical Co LtdCompany GMP cert on recordActive DMF 19818, 38060 · latest filing Feb 2023
- DZD (Heze) Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 31373 · latest filing Jan 2017
- MICROBIOPHARM JAPAN CO LTDJapanCEP Company GMP cert on recordActive DMF 22018 · latest filing Sept 2008
- SYNBIAS PHARMA AGSwitzerlandCEPActive DMF 16258 · latest filing Oct 2002
- ItalyCEP Company GMP cert on record
- NetherlandsCEP
- GermanyCEP Company GMP cert on record
- Zhejiang Hisun Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordInactive DMF 16324 · latest filing Dec 2002
- STERLING BIOTECH LIMITEDIndiaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (8)
Certificates of Suitability on the EDQM register for Epirubicin Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 14 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. Taizhou | CN | CEP 2026-252 - Rev 00 Epirubicin hydrochloride, Code epiru04 | Aug 2026 | — |
| STERLING BIOTECH LIMITED Vadodara | IN | CEP 2015-349 - Rev 01 Epirubicin hydrochloride | Jul 2026 | — |
| TRANSO-PHARM HANDELS GMBH Siek | DE | CEP 2020-294 - Rev 01 Epirubicin hydrochloride, Crystalline | Aug 2025 | Inspected Dec 2025 Germany |
| TAPI NL B.V. Amsterdam | NL | CEP 2003-140 - Rev 03 Epirubicin hydrochloride, Lyophilised | Jul 2025 | — |
| SYNBIAS PHARMA AG Schaffhausen | CH | CEP 2023-380 - Rev 00 Epirubicin hydrochloride | Apr 2025 | — |
| OLON S.P.A. Rodano | IT | CEP 2018-012 - Rev 02 Epirubicin hydrochloride | Jan 2025 | Inspected Mar 2025 Italy |
| DZD (HEZE) PHARMACEUTICAL CO., LTD. Heze City | CN | R1-CEP 2017-005 - Rev 00 Epirubicin hydrochloride | Jun 2023 | — |
| MICROBIOPHARM JAPAN CO., LTD. Tokyo | JP | R1-CEP 2008-025 - Rev 04 Epirubicin hydrochloride | Oct 2021 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (1)
Organisations whose Type II DMFs for Epirubicin Hydrochloride are no longer active. These show a past filing, not current supply.
Show all 1 historical record
- FARMITALIA CARLO ERBA SPAInactive DMF 5359 · filed Apr 1984
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Epirubicin Hydrochloride is an anthracycline antibiotic used as a chemotherapy agent. It interferes with the growth and spread of cancer cells in the body.
Chemical identity
- IUPAC name
- (7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
- Canonical SMILES
- C[C@H]1[C@@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O.Cl
- InChIKey
- MWWSFMDVAYGXBV-FGBSZODSSA-N
- Synonyms
- Ellence API, ellence, epirubicin hcl, farmorubicina, imi-28, nsc-759195, wp-697
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Anthracycline Topoisomerase Inhibitor
- Mechanism of action
- Topoisomerase Inhibitors
- Chemical structure
- Anthracyclines
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Epirubicin Hydrochloride?
9 organisations hold an active US FDA Type II Drug Master File or a CEP for Epirubicin Hydrochloride: Shandong New Time Pharmaceutical Co Ltd, DZD (Heze) Pharmaceutical Co., Ltd. (China), MICROBIOPHARM JAPAN CO LTD (Japan), SYNBIAS PHARMA AG (Switzerland), OLON SPA (Italy), TAPI NL BV (Netherlands), TRANSO PHARM HANDELS GMBH (Germany) and Zhejiang Hisun Pharmaceutical Co., Ltd. (China), and 1 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Epirubicin Hydrochloride Drug Master Files are active?
Shandong New Time Pharmaceutical Co Ltd (DMF 19818, 38060), DZD (Heze) Pharmaceutical Co., Ltd. (DMF 31373), MICROBIOPHARM JAPAN CO LTD (DMF 22018) and SYNBIAS PHARMA AG (DMF 16258). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Epirubicin Hydrochloride records mean?
1 organisation has only inactive Type II DMFs for Epirubicin Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Epirubicin Hydrochloride have a European Certificate of Suitability?
Yes. 8 organisations hold a valid CEP for Epirubicin Hydrochloride on the EDQM register, including ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. Taizhou (CN), STERLING BIOTECH LIMITED Vadodara (IN), TRANSO-PHARM HANDELS GMBH Siek (DE), TAPI NL B.V. Amsterdam (NL), SYNBIAS PHARMA AG Schaffhausen (CH) and OLON S.P.A. Rodano (IT) and 2 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Epirubicin Hydrochloride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Epirubicin Hydrochloride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.